CMCSA(CMCSA)
CMCSA
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $121.85B | $120.27B | $123.21B | $121.92B | $125.79B |
| Low | $120.48B | $118.77B | $123.12B | $119.96B | $123.77B |
| High | $123.01B | $123.22B | $123.30B | $124.07B | $128.00B |
| EBITDA Avg | $55.67B | $54.96B | $56.29B | $55.71B | $57.47B |
| Low | $55.05B | $54.27B | $56.25B | $54.81B | $56.55B |
| High | $56.21B | $56.30B | $56.34B | $56.69B | $58.48B |
| EBIT Avg | $38.48B | $37.98B | $38.91B | $38.50B | $39.72B |
| Low | $38.04B | $37.51B | $38.88B | $37.88B | $39.08B |
| High | $38.84B | $38.91B | $38.93B | $39.18B | $40.42B |
| Net Income Avg | $13.01B | $13.79B | $15.30B | $16.59B | $18.89B |
| Low | $11.98B | $12.28B | $13.60B | $16.24B | $18.49B |
| High | $14.04B | $15.30B | $17.01B | $16.97B | $19.32B |
| EPS Avg | $3.51 | $3.79 | $4.20 | $4.56 | $5.19 |
| Low | $3.29 | $3.38 | $3.74 | $4.47 | $5.09 |
| High | $3.86 | $4.21 | $4.68 | $4.67 | $5.31 |
| Analysts (Rev / EPS) | 18 / 15 | 17 / 15 | 15 / 10 | 11 / 4 | 7 / 4 |
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $29.26B | $30.01B | $31.03B | $29.59B | $29.23B | $29.72B | $31.01B | $30.00B |
| Low | $29.12B | $29.73B | $30.50B | $29.08B | $28.73B | $29.21B | $30.48B | $29.49B |
| High | $29.50B | $30.25B | $31.45B | $29.99B | $29.62B | $30.11B | $31.43B | $30.40B |
| EBITDA Avg | $13.37B | $13.71B | $14.18B | $13.52B | $13.36B | $13.58B | $14.17B | $13.71B |
| Low | $13.30B | $13.58B | $13.94B | $13.29B | $13.13B | $13.35B | $13.93B | $13.47B |
| High | $13.48B | $13.82B | $14.37B | $13.70B | $13.53B | $13.76B | $14.36B | $13.89B |
| EBIT Avg | $9.24B | $9.48B | $9.80B | $9.34B | $9.23B | $9.38B | $9.79B | $9.47B |
| Low | $9.19B | $9.39B | $9.63B | $9.18B | $9.07B | $9.22B | $9.63B | $9.31B |
| High | $9.31B | $9.55B | $9.93B | $9.47B | $9.35B | $9.51B | $9.92B | $9.60B |
| Net Income Avg | $3.51B | $3.75B | $2.63B | $2.93B | $3.75B | $3.98B | $3.00B | $3.66B |
| Low | $3.26B | $3.57B | $2.57B | $2.87B | $3.67B | $3.89B | $2.93B | $3.58B |
| High | $3.65B | $3.93B | $2.68B | $2.98B | $3.82B | $4.05B | $3.05B | $3.72B |
| EPS Avg | $0.97 | $1.04 | $0.73 | $0.81 | $1.04 | $1.10 | $0.83 | $1.01 |
| Low | $0.90 | $0.99 | $0.71 | $0.79 | $1.01 | $1.08 | $0.81 | $0.99 |
| High | $1.01 | $1.09 | $0.74 | $0.83 | $1.06 | $1.12 | $0.84 | $1.03 |
| Analysts (Rev / EPS) | 14 / 13 | 13 / 12 | 6 / 10 | 6 / 5 | 6 / 5 | 6 / 5 | 6 / 5 | 5 / 7 |